The Board has determined that the Veteran's essential thrombocytosis is at least as likely as not related to service, including exposure to ionizing radiation during military service. Therefore, service connection for this condition is granted.
The deciding factor: The treating hematologist's opinion supports a finding of service connection due to the likelihood that the disability first manifested in service and was aggravated by service-related exposure to ionizing radiation.
- Claimed conditions
- essential thrombocytosis
- How they argued it
- Aggravation of a pre-existing condition
- Exposure basis
- Ionizing radiation
- Rating
- Not verified here — check the original decision
- Decision date
- June 4, 2020
- Citation
- 20038515
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20038515.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has determined that the evidence is in equipoise regarding whether the Veteran's essential thrombocytosis is related to service, specifically herbicide exposure. As such, the claim for service connection is granted.
- Whole decision: Remanded (sent back)
The Board remands the claim for essential thrombocytosis to obtain an addendum opinion addressing all toxic exposure risks, including herbicides.
- Whole decision: Denied
The Board denied the Veteran's claim for an initial compensable rating for essential thrombocytosis as there was no evidence of continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment.
- Whole decision: Dismissed
The Veteran withdrew his appeal of the denial of service connection for myeloproliferative disease with essential thrombocytosis.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.